secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2024-12-17T23:59:59+00:00
Accession:  0001493152-24-050433
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech receives NYSE American delisting notice for stockholders' equity deficit
--------------------------------------------------------------------------------

- Stockholders' deficit of $2.9M as of Sept 30, 2024; fails $4M and $6M equity thresholds.
- Must submit compliance plan by Jan 10, 2025; cure period until June 11, 2026.
- Stock to trade with ".BC" designation while below compliance; no immediate impact on listing.
- Company has reported net losses in five most recent fiscal years.
- If plan not accepted or compliance not regained, delisting proceedings may commence.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315224050433/0001493152-24-050433-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315224050433/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-050433

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer